Projects
Team
Funding
Join/Contact

yelab@UCSF

Projects
Team
Funding
Join/Contact
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
April 7, 2017
2017
Jimmie Ye
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
Jimmie Ye
April 7, 2017
2017

CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells

Jimmie Ye
April 7, 2017
2017

Source:https://www.nature.com/articles/s41598-017-00462-8

Tagged: Genome Engineering, Immunology

Newer PostPhAT-QTL: A Phase-Aware Test for QTL Detection
Older PostA tissue checkpoint regulates type 2 immunity
Back to Top

Powered by Squarespace